Tanke Biosciences Equity 2024

Tanke Biosciences Aktienanalyse

What does Tanke Biosciences do?

Tanke Biosciences Corp is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune system disorders. The company was founded in 2016 and is headquartered in Beijing, China. Tanke Biosciences aims to provide patients worldwide access to high-quality medicines and improve the chances of recovery for people with serious illnesses. The business model of Tanke Biosciences is based on the discovery and development of new drugs that can be used in clinics and hospitals. The company's main focus is the research of protease inhibitors, molecules that inhibit the activity of enzymes and therefore reduce inflammation. The company has acquired world-leading expertise in the development of protease inhibitors and is one of the most promising companies in the industry in this area. Tanke Biosciences has various divisions in which the company operates. One of the most important divisions is the development of drugs for the treatment of autoimmune diseases. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the protein DPP4. DPP4 is involved in the regulation of the immune system and plays an important role in the development of autoimmune diseases such as diabetes or rheumatoid arthritis. The DPP4 inhibitors of Tanke Biosciences are promising candidates for improved therapy of these diseases. Another division of Tanke Biosciences is the research of cancer therapies. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the enzyme Cathepsin K. Cathepsin K is involved in the development and spread of malignant tumors and thus plays an important role in the fight against cancer. The Cathepsin K inhibitors of Tanke Biosciences are promising for the development of new cancer therapies. Tanke Biosciences also offers other products and services that serve the research of molecular drugs. These include, for example, peptide libraries that researchers can use to identify new drugs. In addition, the company offers comprehensive research services to support customers in drug discovery and development. Overall, Tanke Biosciences is an innovative biopharmaceutical company specializing in the discovery and development of new drugs for the treatment of autoimmune diseases, cancer, and other immune system disorders. With its products and services, the company makes an important contribution to improving the health of people worldwide. Tanke Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Tanke Biosciences's Equity

Tanke Biosciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Tanke Biosciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Tanke Biosciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Tanke Biosciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Tanke Biosciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Tanke Biosciences Stock

What is the equity of Tanke Biosciences this year?

Tanke Biosciences has equity of 0 USD this year.

What was the equity of Tanke Biosciences compared to the previous year?

The equity of Tanke Biosciences has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Tanke Biosciences?

A high equity is advantageous for investors of Tanke Biosciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Tanke Biosciences?

A low equity can be a risk for investors of Tanke Biosciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Tanke Biosciences affect the company?

An increase in equity of Tanke Biosciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Tanke Biosciences affect the company?

A reduction in equity of Tanke Biosciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Tanke Biosciences?

Some factors that can affect the equity of Tanke Biosciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Tanke Biosciences so important for investors?

The equity of Tanke Biosciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Tanke Biosciences take to change the equity?

To change equity, Tanke Biosciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Tanke Biosciences pay?

Over the past 12 months, Tanke Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tanke Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Tanke Biosciences?

The current dividend yield of Tanke Biosciences is .

When does Tanke Biosciences pay dividends?

Tanke Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tanke Biosciences?

Tanke Biosciences paid dividends every year for the past 0 years.

What is the dividend of Tanke Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tanke Biosciences located?

Tanke Biosciences is assigned to the '-' sector.

Wann musste ich die Aktien von Tanke Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tanke Biosciences from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Tanke Biosciences pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of Tanke Biosciences in the year 2023?

In the year 2023, Tanke Biosciences distributed 0 USD as dividends.

In which currency does Tanke Biosciences pay out the dividend?

The dividends of Tanke Biosciences are distributed in USD.